GDxLab Team
CEO : Min-Jeong Kim, PhD
CLIA Director : Xin Yi, PhD
CLIA Director : Xin Yi, PhD
Dr. Min-Jeong Kim is GDXLAB’ founder and CEO. He has supervised clinical laboratory operations under US CAP / CLIA regulation form over 10 years. He is well versed in molecular diagnostics, functional genomics, and molecular medicine. He has been overseeing the R&D laboratory at Diagnomics since 2017, after being the R&D director at our
Dr. Min-Jeong Kim is GDXLAB’ founder and CEO. He has supervised clinical laboratory operations under US CAP / CLIA regulation form over 10 years. He is well versed in molecular diagnostics, functional genomics, and molecular medicine. He has been overseeing the R&D laboratory at Diagnomics since 2017, after being the R&D director at our EONE-Diagnomics Genome Center (EDGC) in Incheon, Korea for over 2 years. Before, he served as the director of the Genomics facility at the Ohio University in Athens, OH. He obtained his PhD in Agricultural Biotechnology at the Seoul National University and his postdoctoral training at the Institute of Biological Chemistry at the Washington State University, WA. He published more than 10 scientific journal articles and is the author of several international patents.
CLIA Director : Xin Yi, PhD
CLIA Director : Xin Yi, PhD
CLIA Director : Xin Yi, PhD
Dr. Xin Yi is a Clinical director of the company. She is board-certified clinical chemist (DABCC) with broad expertise in clinical chemistry, endocrinology testing, therapeutic drug monitoring, toxicology, and clinical pharmacogenetics. She is a fellow of the AACC’s National Academy of Clinical Biochemistry (NACB), and the Co-director o
Dr. Xin Yi is a Clinical director of the company. She is board-certified clinical chemist (DABCC) with broad expertise in clinical chemistry, endocrinology testing, therapeutic drug monitoring, toxicology, and clinical pharmacogenetics. She is a fellow of the AACC’s National Academy of Clinical Biochemistry (NACB), and the Co-director of the ComACC postdoctoral fellowship program at Houston Methodist Hospital. Her clinical services include supervising the professional activities in the sections of general and special chemistry, point of care, and diagnostic immunology. Prior to her current position, she completed her postdoctoral fellowship training in clinical chemistry at the University of Chicago after completing her PhD in clinical-bioanalytical chemistry at Cleveland State University.
Chairman : Min Seob Lee PhD
CLIA Director : Xin Yi, PhD
Chairman : Min Seob Lee PhD
Dr. Min Seob Lee is the chairman of the board of the company. He is a founder and CEO of Diagnomics Inc, in San Diego, CA. He also serves as the co-CEO of the Eone Diagnomics Genome Center (KOSDAQ; EDGC) in Incheon South Korea. He is a visiting professor of Institute of Convergence Science & Technology in Incheon National University and
Dr. Min Seob Lee is the chairman of the board of the company. He is a founder and CEO of Diagnomics Inc, in San Diego, CA. He also serves as the co-CEO of the Eone Diagnomics Genome Center (KOSDAQ; EDGC) in Incheon South Korea. He is a visiting professor of Institute of Convergence Science & Technology in Incheon National University and a director of ShareGenome in California that promotes research in precision medicine and scientific discoveries from genomics and health data. Dr. Lee is a writer of the “Homo Hundred Genome Revolution” book and published numerous scientific articles.
He conducted his post-doctoral fellowship at the Genomics and Proteomics Center at Harvard Medical School and received his Ph.D. degree in Biological Science from City of Hope National Medical Center in Duarte, CA.